The cost of Glucophage can differ significantly by strength, pack size, pharmacy and coverage, while patients must also weigh common side effects and rare safety risks.
Glucophage, the brand name for metformin, remains one of the most widely used medicines for type 2 diabetes, and recent pricing guides show that what patients pay can vary sharply by strength, pack size and pharmacy. According to Drugs.com, the cost of standard tablets can range from roughly $34 for 30 tablets to more than $500 for larger quantities, while extended-release versions also carry their own pricing bands. Generic metformin is widely available, which can make treatment less expensive, but the final bill still depends on location and the discount or insurance arrangement used at the point of sale.
The medicine’s active ingredient is metformin hydrochloride. Pharmaceutical references including Vidal list Glucophage tablets in 500 mg, 850 mg and 1,000 mg strengths, with each tablet containing a different amount of metformin base. The same sources say the tablets also include inactive ingredients such as povidone and magnesium stearate, with coating materials varying by strength. Pharmabolix describes Glucophage as a treatment for type 2 diabetes, particularly when diet and exercise alone are not enough to restore normal glucose control, especially in people who are overweight.
Like all metformin products, Glucophage comes with important safety warnings. Drugs.com says the medicine can cause stomach side effects such as diarrhoea, nausea and abdominal discomfort, and it carries a rare but serious risk of lactic acidosis, a dangerous build-up of lactic acid in the blood. The site also notes that patients may need to stop taking it temporarily before certain medical procedures, a precaution that is standard in prescribing information. Vidal likewise highlights contraindications and situations in which treatment may need to be paused.
For patients trying to manage long-term costs, pricing guides point to a familiar pattern: the smaller the pack, the lower the absolute price, but the per-tablet cost can still be significant without coverage. Drugs.com says discount cards and patient assistance programmes may help reduce out-of-pocket spending, although prices can change from one pharmacy to another. The broader picture is that Glucophage remains a core diabetes medicine, but access is shaped as much by retail pricing and insurance design as by clinical need.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
